ZS Pharma, Inc. Costs and Expenses
ZS Pharma, Inc. reported Costs and Expenses of $35.25 million for the 3-month period ending 2015-09-30, per its 10-Q filed 2015-11-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:CostsAndExpenses · last filed 2015-11-09
- ZS Pharma, Inc. costs and expenses for the quarter ending 2015-09-30 was $35.25M, a 112.04% increase year-over-year.
- ZS Pharma, Inc. costs and expenses for the quarter ending 2015-06-30 was $32.45M, a 123.35% increase year-over-year.
- ZS Pharma, Inc. costs and expenses for the quarter ending 2015-03-31 was $21.72M, a 134.16% increase year-over-year.
- ZS Pharma, Inc. costs and expenses for the quarter ending 2014-12-31 was $20.11M, a 93.34% increase year-over-year.
- ZS Pharma, Inc. costs and expenses for fiscal 2014 was $60.54M, a 88.04% increase from fiscal 2013.
- ZS Pharma, Inc. costs and expenses for fiscal 2013 was $32.19M, a 295.65% increase from fiscal 2012.
- ZS Pharma, Inc. costs and expenses for fiscal 2012 was $8.14M.
| Period end | Costs and Expenses 3 month | Costs and Expenses 6 month | Costs and Expenses 9 month | Costs and Expenses 12 month |
|---|---|---|---|---|
| 2015-09-30 | $35.25M 10-Q · filed 2015-11-09 | $67.70M derived: sum of 2 quarters · filed 2015-11-09 | $89.42M 10-Q · filed 2015-11-09 | $109.53M derived: sum of 4 quarters · filed 2015-11-09 |
| 2015-06-30 | $32.45M 10-Q · filed 2015-08-06 | $54.17M 10-Q · filed 2015-08-06 | $74.28M derived: sum of 3 quarters · filed 2015-08-06 | $90.91M derived: sum of 4 quarters · filed 2015-11-09 |
| 2015-03-31 | $21.72M 10-Q · filed 2015-05-11 | $41.83M derived: sum of 2 quarters · filed 2015-05-11 | $58.45M derived: sum of 3 quarters · filed 2015-11-09 | $72.98M derived: sum of 4 quarters · filed 2015-11-09 |
| 2014-12-31 | $20.11M 10-K · filed 2015-03-13 | $36.73M derived: sum of 2 quarters · filed 2015-11-09 | $51.26M derived: sum of 3 quarters · filed 2015-11-09 | $60.54M 10-K · filed 2015-03-13 |
| 2014-09-30 | $16.62M 10-Q · filed 2015-11-09 | $31.15M derived: sum of 2 quarters · filed 2015-11-09 | $40.43M 10-Q · filed 2015-11-09 | $50.83M derived: sum of 4 quarters · filed 2015-11-09 |
| 2014-06-30 | $14.53M 10-Q · filed 2015-08-06 | $23.81M 10-Q · filed 2015-08-06 | $34.21M derived: sum of 3 quarters · filed 2015-08-06 | $43.57M derived: sum of 4 quarters · filed 2015-08-06 |
| 2014-03-31 | $9.28M 10-Q · filed 2015-05-11 | $19.68M derived: sum of 2 quarters · filed 2015-05-11 | $29.04M derived: sum of 3 quarters · filed 2015-05-11 | $36.35M derived: sum of 4 quarters · filed 2015-05-11 |
| 2013-12-31 | $10.40M 10-K · filed 2015-03-13 | $19.76M derived: sum of 2 quarters · filed 2015-03-13 | $27.07M derived: sum of 3 quarters · filed 2015-03-13 | $32.19M 10-K · filed 2015-03-13 |
| 2013-09-30 | $9.36M 10-K · filed 2015-03-13 | $16.67M derived: sum of 2 quarters · filed 2015-03-13 | $21.79M 10-Q · filed 2014-11-10 | |
| 2013-06-30 | $7.31M 10-K · filed 2015-03-13 | $12.43M 10-Q · filed 2014-08-14 | ||
| 2013-03-31 | $5.12M 10-K · filed 2015-03-13 | |||
| 2012-12-31 | $8.14M 10-K · filed 2015-03-13 |